189 related articles for article (PubMed ID: 20421792)
1. Statins and inflammation: an update.
Quist-Paulsen P
Curr Opin Cardiol; 2010 Jul; 25(4):399-405. PubMed ID: 20421792
[TBL] [Abstract][Full Text] [Related]
2. Interpreting the JUPITER trial: statins can prevent VTE, but more study is needed.
Perez A; Bartholomew JR
Cleve Clin J Med; 2010 Mar; 77(3):191-4. PubMed ID: 20200169
[TBL] [Abstract][Full Text] [Related]
3. Statins targeting inflammation by lowering low-density lipoprotein?
Tuzcu EM; Nicholls SJ
J Am Coll Cardiol; 2007 May; 49(20):2010-2. PubMed ID: 17512356
[No Abstract] [Full Text] [Related]
4. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
5. Predicting benefit from statins by C-reactive protein, LDL-cholesterol or absolute cardiovascular risk.
Stewart RA
Future Cardiol; 2009 May; 5(3):231-6. PubMed ID: 19656039
[TBL] [Abstract][Full Text] [Related]
6. [Additional effects of statins independent of the cholesterol-lowering as yet not shown to be clinically relevant].
Visseren FL; Lansberg PJ; Erkelens DW; Kastelein JJ
Ned Tijdschr Geneeskd; 2000 Apr; 144(17):822-3. PubMed ID: 10800556
[No Abstract] [Full Text] [Related]
7. Immunomodulation by statins: inhibition of cholesterol vs. isoprenoid biosynthesis.
Kuipers HF; van den Elsen PJ
Biomed Pharmacother; 2007 Aug; 61(7):400-7. PubMed ID: 17643927
[TBL] [Abstract][Full Text] [Related]
8. Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein: a meta-analysis.
Kinlay S
J Am Coll Cardiol; 2007 May; 49(20):2003-9. PubMed ID: 17512355
[TBL] [Abstract][Full Text] [Related]
9. Effects of statins on inflammation in patients with acute and chronic coronary syndromes.
Kinlay S; Selwyn AP
Am J Cardiol; 2003 Feb; 91(4A):9B-13B. PubMed ID: 12615293
[TBL] [Abstract][Full Text] [Related]
10. Statins and stroke prevention.
Paciaroni M; Bogousslavsky J
Expert Rev Cardiovasc Ther; 2009 Oct; 7(10):1231-43. PubMed ID: 19814666
[TBL] [Abstract][Full Text] [Related]
11. Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia.
Joukhadar C; Klein N; Prinz M; Schrolnberger C; Vukovich T; Wolzt M; Schmetterer L; Dorner GT
Thromb Haemost; 2001 Jan; 85(1):47-51. PubMed ID: 11204586
[TBL] [Abstract][Full Text] [Related]
12. [About: pleiotropic effects of statins in atherosclerosis].
Ambrosi P
Arch Mal Coeur Vaiss; 2005 Dec; 98(12):1263; author reply 1263-5. PubMed ID: 16435610
[No Abstract] [Full Text] [Related]
13. The nonlipid effects of statins on endothelial function.
Beckman JA; Creager MA
Trends Cardiovasc Med; 2006 Jul; 16(5):156-62. PubMed ID: 16781949
[TBL] [Abstract][Full Text] [Related]
14. Benefits of the statins: beyond cholesterol.
Harv Mens Health Watch; 2001 Aug; 6(1):1-5. PubMed ID: 11546633
[No Abstract] [Full Text] [Related]
15. The use over time of statins in coronary patients in an Italian tertiary referral center.
Gaspardone A; Proietti I; Altamura L; Tomai F; Versaci F; Crea F; Chiariello L; Gioffrè PA
Ital Heart J; 2001 Nov; 2(11):848-53. PubMed ID: 11770871
[TBL] [Abstract][Full Text] [Related]
16. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
[TBL] [Abstract][Full Text] [Related]
17. [Prevention and therapy of vascular damage and endothelial dysfunction with hypocholesteremic agents].
De Caterina R; Lenzi S
G Ital Cardiol; 1998 Feb; 28(2):168-77. PubMed ID: 9534058
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory effects of HMG-CoA reductase inhibitors.
Danesh FR; Anel RL; Zeng L; Lomasney J; Sahai A; Kanwar YS
Arch Immunol Ther Exp (Warsz); 2003; 51(3):139-48. PubMed ID: 12894868
[TBL] [Abstract][Full Text] [Related]
19. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
Gotto AM; Farmer JA
Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799
[TBL] [Abstract][Full Text] [Related]
20. Statin therapy for elevated hsCRP: what are the public health implications?
Ridker PM
Am J Manag Care; 2010 Aug; 16(8):561-2. PubMed ID: 20712388
[No Abstract] [Full Text] [Related]
[Next] [New Search]
